CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	$ (79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021		14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	52	$ 52
Exercise of stock options (in shares)		10,669
Restricted stock issued		30,087
Net share settlement of stock options and restricted stock units	(257)	$ (257)
Net share settlement of stock options and restricted stock units (in shares)		(11,339)
Stock-based compensation expense	232	$ 232
Repurchase and retirement of common stock	(1,356)		(1,356)
Repurchase and retirement of common stock (in shares)		(47,350)
Net Income Loss	1,719		1,719
Balance, end of period at May. 01, 2021	95,312	$ 174,418	(79,106)
Balance, end of period (in shares) at May. 01, 2021		14,274,317
Balance, beginning of period at Jan. 30, 2021	94,922	$ 174,391	(79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021		14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 146
Repurchase and retirement of common stock (in shares)	(1,414,642)
Net Income Loss	$ 9,574
Balance, end of period at Oct. 30, 2021	$ 75,763	$ 175,479	(99,716)
Balance, end of period (in shares) at Oct. 30, 2021	13,007,409	13,007,409
Balance, beginning of period at May. 01, 2021	$ 95,312	$ 174,418	(79,106)
Balance, beginning of period (in shares) at May. 01, 2021		14,274,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	94	$ 94
Exercise of stock options (in shares)		20,168
Restricted stock issued		79,775
Net share settlement of stock options and restricted stock units	(73)	$ (73)
Net share settlement of stock options and restricted stock units (in shares)		7,582
Stock-based compensation expense	651	$ 651
Repurchase and retirement of common stock	(12,008)		(12,008)
Repurchase and retirement of common stock (in shares)		(561,548)
Net Income Loss	626		626
Balance, end of period at Jul. 31, 2021	84,602	$ 175,090	(90,488)
Balance, end of period (in shares) at Jul. 31, 2021		13,805,130
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued		10,606
Net share settlement of stock options and restricted stock units	(49)	$ (49)
Net share settlement of stock options and restricted stock units (in shares)		(2,583)
Stock-based compensation expense	438	$ 438
Repurchase and retirement of common stock	$ (16,457)		(16,457)
Repurchase and retirement of common stock (in shares)	(805,744)	(805,744)
Net Income Loss	$ 7,229		7,229
Balance, end of period at Oct. 30, 2021	$ 75,763	$ 175,479	(99,716)
Balance, end of period (in shares) at Oct. 30, 2021	13,007,409	13,007,409
Balance, beginning of period at Jan. 29, 2022	$ 81,126	$ 175,856	(94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022	12,631,347	12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 16	$ 16
Exercise of stock options (in shares)		2,705
Restricted stock issued		797,849
Net share settlement of stock options and restricted stock units	(2,375)	$ (2,375)
Net share settlement of stock options and restricted stock units (in shares)		(224,320)
Stock-based compensation expense	548	$ 548
Repurchase and retirement of common stock	(6,253)		(6,253)
Repurchase and retirement of common stock (in shares)		(479,966)
Net Income Loss	(7,855)		(7,855)
Balance, end of period at Apr. 30, 2022	65,207	$ 174,045	(108,838)
Balance, end of period (in shares) at Apr. 30, 2022		12,727,615
Balance, beginning of period at Jan. 29, 2022	$ 81,126	$ 175,856	(94,730)
Balance, beginning of period (in shares) at Jan. 29, 2022	12,631,347	12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 16
Repurchase and retirement of common stock (in shares)	(479,966)
Net Income Loss	$ (40,901)
Balance, end of period at Oct. 29, 2022	$ 33,065	$ 174,949	(141,884)
Balance, end of period (in shares) at Oct. 29, 2022	12,754,368	12,754,368
Balance, beginning of period at Apr. 30, 2022	$ 65,207	$ 174,045	(108,838)
Balance, beginning of period (in shares) at Apr. 30, 2022		12,727,615
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued		28,574
Net share settlement of stock options and restricted stock units	(8)	$ (8)
Net share settlement of stock options and restricted stock units (in shares)		(1,821)
Stock-based compensation expense	617	$ 617
Net Income Loss	(25,705)		(25,705)
Balance, end of period at Jul. 30, 2022	40,111	$ 174,654	(134,543)
Balance, end of period (in shares) at Jul. 30, 2022		12,754,368
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 295	$ 295
Repurchase and retirement of common stock (in shares)	0
Net Income Loss	$ (7,341)		(7,341)
Balance, end of period at Oct. 29, 2022	$ 33,065	$ 174,949	$ (141,884)
Balance, end of period (in shares) at Oct. 29, 2022	12,754,368	12,754,368